Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zhi-Hua Bu"'
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 2, Pp 529-538 (2022)
Background/purpose: Roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor, promotes erythropoiesis and regulates iron metabolism. This study investigated the efficacy and safety of roxadustat in Chinese patients with anem
Externí odkaz:
https://doaj.org/article/ffdfbfe08c9b415aa27421178293fba0
Autor:
Li-Li Zhou, Shu-E Zhang, Jiao Liu, Hong-Ni Wang, Li Liu, Jing-Jing Zhou, Zhi-Hua Bu, Yu-Fang Gao, Tao Sun, Bei Liu
Publikováno v:
Frontiers in Public Health, Vol 9 (2022)
Background: To investigate the prevalence of burnout syndrome among Chinese female nurses during the controlled coronavirus disease 2019 (COVID-19) period and explore its associated socio-demographic factors and job characteristics.Methods: With the
Externí odkaz:
https://doaj.org/article/f7bd4ae646ac4989af0793a74b9b78f1
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 2, Pp 529-538 (2022)
Background/purpose Roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor, promotes erythropoiesis and regulates iron metabolism. This study investigated the efficacy and safety of roxadustat in Chinese patients with anemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c738c1954d211357572c34f59c6ff1
https://pubmed.ncbi.nlm.nih.gov/34167878
https://pubmed.ncbi.nlm.nih.gov/34167878